JP2011507859A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011507859A5 JP2011507859A5 JP2010539516A JP2010539516A JP2011507859A5 JP 2011507859 A5 JP2011507859 A5 JP 2011507859A5 JP 2010539516 A JP2010539516 A JP 2010539516A JP 2010539516 A JP2010539516 A JP 2010539516A JP 2011507859 A5 JP2011507859 A5 JP 2011507859A5
- Authority
- JP
- Japan
- Prior art keywords
- connexin
- composition
- polynucleotide
- oligonucleotide
- item
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US874807P | 2007-12-21 | 2007-12-21 | |
| PCT/US2008/014024 WO2009085273A2 (en) | 2007-12-21 | 2008-12-22 | Use of anti-connexin polynucleotides for the treatment of surgical adhesions |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014173528A Division JP2015013880A (ja) | 2007-12-21 | 2014-08-28 | 外科的癒着の治療のための抗コネキシンポリヌクレオチドの使用 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2011507859A JP2011507859A (ja) | 2011-03-10 |
| JP2011507859A5 true JP2011507859A5 (cg-RX-API-DMAC7.html) | 2013-04-25 |
Family
ID=40824957
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010539516A Pending JP2011507859A (ja) | 2007-12-21 | 2008-12-22 | 外科的癒着の治療のための抗コネキシンポリヌクレオチドの使用 |
| JP2014173528A Pending JP2015013880A (ja) | 2007-12-21 | 2014-08-28 | 外科的癒着の治療のための抗コネキシンポリヌクレオチドの使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014173528A Pending JP2015013880A (ja) | 2007-12-21 | 2014-08-28 | 外科的癒着の治療のための抗コネキシンポリヌクレオチドの使用 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20110144182A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP2252689A2 (cg-RX-API-DMAC7.html) |
| JP (2) | JP2011507859A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2008343754A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2710227A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2009085273A2 (cg-RX-API-DMAC7.html) |
| ZA (1) | ZA201005220B (cg-RX-API-DMAC7.html) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5964538B2 (ja) | 2005-02-03 | 2016-08-03 | コーダ セラピューティクス， インコーポレイテッド | 抗コネキシン化合物およびそれらの使用 |
| AU2008343841A1 (en) | 2007-12-21 | 2009-07-09 | Coda Therapeutics, Inc. | Use of inhibitors of connexin43 for treatment of fibrotic conditions |
| US8785713B2 (en) * | 2010-04-13 | 2014-07-22 | Kci Licensing, Inc. | Compositions with reactive ingredients, and wound dressings, apparatuses, and methods |
| CN104271142B (zh) | 2012-03-01 | 2017-07-04 | 福斯特斯特林研究公司 | 含有α连接蛋白C‑末端(ACT)肽的局部凝胶 |
| WO2013148736A1 (en) | 2012-03-27 | 2013-10-03 | Coda Therapeutics, Inc. | Compositions and treatments based on cadherin modulation |
| US20130259854A1 (en) * | 2012-04-02 | 2013-10-03 | Saint Louis University, A Non-Profit Organization | Methods and compositions for reducing the incidence of post-surgical adhesions |
| CA2958879A1 (en) | 2014-08-22 | 2016-02-25 | Auckland Uniservices Limited | Channel modulators |
| CN111201247A (zh) | 2017-04-28 | 2020-05-26 | 奥克兰联合服务有限公司 | 治疗方法和新颖构建体 |
| JP2023546757A (ja) | 2020-10-22 | 2023-11-07 | シークエル・バイオ・インコーポレイテッド | ペプチド製剤および眼科におけるその使用 |
Family Cites Families (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3687808A (en) * | 1969-08-14 | 1972-08-29 | Univ Leland Stanford Junior | Synthetic polynucleotides |
| US5034506A (en) * | 1985-03-15 | 1991-07-23 | Anti-Gene Development Group | Uncharged morpholino-based polymers having achiral intersubunit linkages |
| CA1322714C (en) * | 1986-11-14 | 1993-10-05 | Harry N. Antoniades | Wound healing and bone regeneration |
| JPH0539594Y2 (cg-RX-API-DMAC7.html) * | 1988-08-05 | 1993-10-07 | ||
| US5166195A (en) * | 1990-05-11 | 1992-11-24 | Isis Pharmaceuticals, Inc. | Antisense inhibitors of the human immunodeficiency virus phosphorothioate oligonucleotides |
| US6752987B1 (en) * | 1995-02-28 | 2004-06-22 | The Regents Of The University Of California | Adenovirus encoding human adenylylcyclase (AC) VI |
| US20030148968A1 (en) * | 1995-02-28 | 2003-08-07 | Hammond H. Kirk | Techniques and compositions for treating cardiovascular disease by in vivo gene delivery |
| WO1999007844A2 (en) * | 1997-08-07 | 1999-02-18 | The United States Of America, Represented By The Secretary, Department Of Health And Human Services | Methods and compositions for treatment of restenosis |
| EP1037981A1 (en) * | 1997-12-09 | 2000-09-27 | Children's Medical Center Corporation | Soluble inhibitors of vascular endothelial growth factor and use thereof |
| US6506559B1 (en) * | 1997-12-23 | 2003-01-14 | Carnegie Institute Of Washington | Genetic inhibition by double-stranded RNA |
| ES2498745T3 (es) * | 1999-01-27 | 2014-09-25 | Coda Therapeutics, Inc. | Formulaciones que comprenden nucleótidos antisentido para conexinas |
| US5998148A (en) * | 1999-04-08 | 1999-12-07 | Isis Pharmaceuticals Inc. | Antisense modulation of microtubule-associated protein 4 expression |
| WO2002032940A2 (en) * | 2000-10-18 | 2002-04-25 | Children's Medical Center Corporation | Osteopontin-coated surfaces and methods of use |
| US20050119211A1 (en) * | 2001-05-18 | 2005-06-02 | Sirna Therapeutics, Inc. | RNA mediated inhibition connexin gene expression using short interfering nucleic acid (siNA) |
| JP2005509621A (ja) * | 2001-10-17 | 2005-04-14 | ユニバーシティ オブ ウェールズ カレッジ オブ メディスン | ギャップ結合ならびにｅｄｈｆ |
| EA006860B1 (ru) * | 2002-01-29 | 2006-04-28 | Уайт | Композиции и способы модулирования гемиканалов коннексина |
| AU2003234613A1 (en) * | 2002-05-15 | 2003-12-02 | Seul, Kyung, Hwan | Method of modulating angiogenesis |
| WO2004021861A2 (en) * | 2002-09-03 | 2004-03-18 | Vit Lauermann | Targeted release |
| WO2006006948A2 (en) * | 2002-11-14 | 2006-01-19 | Dharmacon, Inc. | METHODS AND COMPOSITIONS FOR SELECTING siRNA OF IMPROVED FUNCTIONALITY |
| CA3059497A1 (en) * | 2003-12-03 | 2005-06-16 | Ocunexus Therapeutics, Inc. | Antisense compounds targeted to connexins and methods of use thereof |
| TR201907874T4 (tr) * | 2004-09-23 | 2019-06-21 | Arc Medical Devices Inc | Düşük sülfat fukanlar kullanarak fibröz yapışmaları ya da inflamatuar hastalıkları inhibe etmeye yönelik farmasötik kompozisyonlar ve yöntemler. |
| JP5964538B2 (ja) * | 2005-02-03 | 2016-08-03 | コーダ セラピューティクス， インコーポレイテッド | 抗コネキシン化合物およびそれらの使用 |
| WO2007068252A2 (en) * | 2005-12-16 | 2007-06-21 | Arla Foods Amba | Bovine osteopontin formulations for the improvement of the wound healing process |
| EP2114422A1 (en) * | 2007-03-02 | 2009-11-11 | National University of Ireland, Galway | Osteopontin for the prediction and treatment of cardiovascular diseases |
| CN101970663A (zh) * | 2007-12-11 | 2011-02-09 | 科达治疗公司 | 受损伤口愈合的组合物和治疗 |
-
2008
- 2008-12-22 CA CA2710227A patent/CA2710227A1/en not_active Abandoned
- 2008-12-22 WO PCT/US2008/014024 patent/WO2009085273A2/en not_active Ceased
- 2008-12-22 EP EP08866069A patent/EP2252689A2/en not_active Withdrawn
- 2008-12-22 JP JP2010539516A patent/JP2011507859A/ja active Pending
- 2008-12-22 AU AU2008343754A patent/AU2008343754A1/en not_active Abandoned
- 2008-12-22 US US12/809,933 patent/US20110144182A1/en not_active Abandoned
-
2010
- 2010-07-21 ZA ZA2010/05220A patent/ZA201005220B/en unknown
-
2014
- 2014-08-28 JP JP2014173528A patent/JP2015013880A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2011507859A5 (cg-RX-API-DMAC7.html) | ||
| JP5607176B2 (ja) | 新規ペプチドおよびその用途 | |
| US8668703B2 (en) | Medical devices incorporating collagen inhibitors | |
| US20090180965A1 (en) | Methods for repair and regeneration of bone marrow | |
| JP4307561B2 (ja) | 創傷の治癒 | |
| JP2011507858A5 (cg-RX-API-DMAC7.html) | ||
| JP2014208699A (ja) | 外科的癒着の治療のための、単独のまたは抗コネキシンポリヌクレオチドと組み合わせた抗コネキシンペプチドの使用 | |
| KR20120014251A (ko) | 동종이식편의 접합을 개선하기 위한 생체활성 코팅 조성물 및 방법 | |
| US9782522B2 (en) | Compositions and methods for treating and preventing neointimal stenosis | |
| JP2011507855A5 (cg-RX-API-DMAC7.html) | ||
| Hildebrand et al. | Joint capsule matrix turnover in a rabbit model of chronic joint contractures: correlation with human contractures | |
| DE602005025347D1 (de) | Oligoribonukleotide und verfahren zu deren anwendung bei der behandlung von fibrotischen leiden und anderen krankheiten | |
| WO2013059879A1 (en) | Compositions and methods for the treatment of fibrosis and fibrotic diseases | |
| CN105078889B (zh) | 一种用于治疗软骨疾病的脂质体递送系统及其制备方法 | |
| TW201023879A (en) | Method of inhibiting and/or rescuing cell terminal differentiation, and composition for treating and/or inhibiting arthritis | |
| JP7514563B2 (ja) | オルガノイドおよび抗炎症剤を含む炎症性腸疾患の予防または治療用薬学組成物 | |
| RU2425669C1 (ru) | Средство для профилактики и лечения острого и хронического панкреатита | |
| US20180214388A1 (en) | Composition and method for reducing scarring | |
| Meisel et al. | Sunitinib inhibits postoperative adhesions in a rabbit model | |
| US10596192B2 (en) | Treating rotator cuff conditions | |
| CN115120729B (zh) | 跨膜蛋白41b作为药物靶标在制备治疗病理性心肌肥厚药物中的应用 | |
| DE502007003367D1 (de) | Pharmazeutische zusammensetzung zur behandlung von inkontinenz | |
| CN118217295A (zh) | 25-羟基胆固醇在制备骨质疏松和骨溶解症治疗药物中的应用 | |
| JP2018518453A (ja) | 糖尿病創傷治療用イソキノリン誘導体の新規使用 | |
| CN103948617A (zh) | 一种治疗和预防腹部手术后粘连的药物组合物 |